Information:
Error:
ID
30805
Description
Study part: Pharmacokinetics Blood GW786034 Follow- up. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Keywords
Versions (1)
- 6/20/18 6/20/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
June 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacokinetics Blood GW786034 Follow- up Pazopanib Macular Degeneration MD1103367
Pharmacokinetics Blood GW786034 Follow- up
- StudyEvent: ODM
Similar models
Pharmacokinetics Blood GW786034 Follow- up
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
PHARMACOKINETICS BLOOD - GW786034 (PK)
C0031327 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
C1522577 (UMLS CUI-4)
C0005767 (UMLS CUI-2)
C1522577 (UMLS CUI-4)
Time
Item
Actual time
time
C0040223 (UMLS CUI [1])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
No comments